Shinpoong Pharmaceutical Co.,Ltd (KRX:019175)
South Korea
· Delayed Price · Currency is KRW 25,600
+300 (1.19%)
At close: Dec 5, 2025
KRX:019175 Revenue
Shinpoong Pharmaceutical Co.,Ltd had revenue of 62.61B KRW in the quarter ending September 30, 2025, with 12.21% growth. This brings the company's revenue in the last twelve months to 231.90B, up 7.64% year-over-year. In the year 2024, Shinpoong Pharmaceutical Co.,Ltd had annual revenue of 221.09B with 10.42% growth.
Revenue (ttm)
231.90B
Revenue Growth
+7.64%
P/S Ratio
3.36
Revenue / Employee
286.65M
Employees
809
Market Cap
778.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 221.09B | 20.87B | 10.42% |
| Dec 31, 2023 | 200.23B | -9.06B | -4.33% |
| Dec 31, 2022 | 209.29B | 20.05B | 10.60% |
| Dec 31, 2021 | 189.24B | -8.51B | -4.31% |
| Dec 31, 2020 | 197.75B | 8.03B | 4.23% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |